Biotech company gets OK to test new flu vaccine

10/29/2004 | USA Today

The FDA will allow Protein Sciences, a small, Connecticut-based biotech company, to administer advanced testing of its cell-culture flu vaccine in 500 people ages 18 to 49 in the U.S. Rather than chicken eggs, the vaccine is made in cell cultures. If the drug works, it could be on the U.S. market by 2007.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC